# Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder

> **NCT00182013** · PHASE4 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 106 (actual)

## Conditions studied

- Bipolar Spectrum Disorder

## Interventions

- **DRUG:** Risperidone
- **DRUG:** Olanzapine
- **DRUG:** Quetiapine

## Key facts

- **NCT ID:** NCT00182013
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2004-02
- **Final completion:** —
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2013-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00182013

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00182013, "Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00182013. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*